CAS: 57576-44-0 - aclarubicin free base

Formule : C₄₂H₅₃NO₁₅

InChI : InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1

Code InChI : InChIKey=USZYSDMBJDPRIF-SVEJIMAYSA-N

SMILES : O=C1C=2C=CC=C(O)C2C(=O)C=3C(O)=C4C(=CC13)C(C(=O)OC)C(O)(CC)CC4OC5OC(C)C(OC6OC(C)C(OC7OC(C(=O)CC7)C)C(O)C6)C(N(C)C)C5

Synonymes :

• 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, (1R,2R,4S)-
• 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-<span class="text-smallcaps">L</smallcap>-lyxo-hexopyranosyl]-3-(dimethylamino)-α-<smallcap>L</span>-lyxo-hexopyranosyl]oxy]-, methyl ester, [1R-(1α,2β,4β)]-
• Aclacinomycin A
• Aclacinomycin A, Streptomycesgalilaeus
• Aclacur
• Aclarubicin
• Antibiotic 3082A
• Antibiotic 77-3082A
• Antibiotic MA 144A1
• Jaclacin
• NSC 208734
• methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-({2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxotetrahydro-2H-pyran-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
• methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[(3xi)-2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-threo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
• methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl}-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

Aclacinomycin A

CAS : 57576-44-0

• Formule : C₄₂H₅₃NO₁₅
• Degré de pureté : ≥ 90.%
• Couleur et forme : Yellow to orange powder or solid
• Masse moléculaire : 811.87

Aclacinomycin A

CAS : 57576-44-0

Aclacinomycin A (Aclarubicin) is a novel anthracycline antibiotic isolated from Streptomyces galilei with antitumor activity.Aclacinomycin …

• Formule : C₄₂H₅₃NO₁₅
• Degré de pureté : 99.43%
• Couleur et forme : Solid
• Masse moléculaire : 811.87

Aclarubicin

CAS : 57576-44-0

• Formule : C₄₂H₅₃NO₁₅
• Masse moléculaire : 811.88

Aclarubicin-13C-d3

CAS : 57576-44-0

• Formule : C₄₁₁₃CH₅₀D₃NO₁₅
• Masse moléculaire : 815.89

Aclarubicin

CAS : 57576-44-0

Applications Aclarubicin is an anthracycline antibiotic. It is used in the treatment of cancer. References …

• Formule : C₄₂H₅₃NO₁₅
• Couleur et forme : Dark Yellow Solid
• Masse moléculaire : 811.87

Aclacinomycin A

CAS : 57576-44-0

Dual inhibitor of topoisomerase I and II

• Formule : C₄₂H₅₃NO₁₅
• Degré de pureté : Min. 95%
• Couleur et forme : Powder
• Masse moléculaire : 811.87 g/mol

Aclarubicin-13CD3

CAS : 57576-44-0

• Formule : CC₄₁D₃H₅₀NO₁₅
• Couleur et forme : Neat
• Masse moléculaire : 815.879